Diabetic Patients That Stop Taking Metformin Could Face Serious Health Complications

While it is inconvenient to be able no longer to find Zantac on a pharmacy's shelves, diabetic patients that have had their Metformin recalled could face serious health risks

Tuesday, June 16, 2020 - The recall of Metformin, a front-line medicine for the treatment of Type 2 diabetes, and manufactured by five different leading drug companies may have the effect of creating confusion and cause patients whose lives depend on diabetes medication to stop taking it. The five companies issuing voluntary recalls are Teva Pharmaceuticals USA, Lupin, Apotex, Anmeal Pharmaceuticals, and Marksans Pharma... "due to evaluated levels of a nitrosamine impurity, N-nitrosodimethylamine (NDMA), a potential carcinogen," according to DCAT Pharmanews.org. NDMA previously existed in safe levels in most drug tablets. The level of NDMA may elevate and cause a cancer concern when drugs are exposed to high storage temperatures, interacting with nitrates in the stomach, and potentially due to contamination at overseas manufacturing plants.

The most recent recall was by Apotex, which recalled their Metformin Hydrochloride Extended-Release 500 mg tablets even though the company has not received any report of a person harmed by the alleged impurities. According to News Medical Life Sciences: "Apotex, Inc. has recalled the nine lots, including PK3968, PK3969, PX5336, PY7174, PY7175, RF6463, RF6464, RF6465, and RF6466." The company states on the Apotex website that the recall is out of an abundance of caution. Zantac antacid cancer lawsuit attorneys are offering a no obligation and free consultation to people suffering with stomach cancer due to taking Zantac antacid.

Online drug testing pharmacy Valisure has detected elevated levels of NDMA in Zantac, the world's best selling heartburn and acid reflux medicine that resulted in Sanofi recalling the drug from store shelves. Individuals have filed lawsuits claiming the popular heartburn medication caused them to stomach cancer, bladder cancer, breast cancer, testicular cancer, and several other types. Patients that relied on Zantac for heartburn relief do not have the same life-threatening implications that a diabetic patient faces should he/she not be able to take their medicine any longer. Metformin is a sodium-glucose blocker drug taken by diabetic patients that do not wish to inject themselves daily with insulin. The recalls are said to have made diabetic patients nervous and uncertain since they may no longer be able to get their prescription drug of choice.

Diabetes doctors are urging their patients to remain calm and to continue to take their drugs as prescribed. One medical doctor has gone on record as offering the following advice to diabetic patients affected by the drug's recall. "Those taking the immediate-release form should continue to take that form of Metformin. Those taking the extended-release form should consult their physician. The good thing is that there are several medication options for the treatment of type 2 diabetes. Patients unable to take Metformin should explore other options with their physicians." Metformin drugs have different gastrological side effects depending on whether they are slow, intermediate, or long-term release. Doctors also advise that diabetic patients continue to practice strict lifestyle improvements like eating more plant-based meals, reducing stress, and losing weight. Physicians may recommend switching to canagliflozin, dapagliflozin, orempagliflozin.

More Recent Heartburn MedicineLawsuit News:

• Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
• Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
• Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
• The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
• Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
• Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
• Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
• A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
• Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
• Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
• Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
• Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
• The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
• Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
• Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
• Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
• Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
• Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
• Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
• Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.